podcast

R&D

Challenges and opportunities in synthetic clinical trials

Of the many changes coming to clinical trials, one of the biggest potential paradigm shifts on the horizon is the elimination of placebo groups in some trials in favour of synthetic control

Digital

The commercialisation of quantum science in pharma

In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and co

Patients

Conference report: Reuters Pharma Europe

In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts edito

R&D

pharmaphorum podcast episode 132a - woman on her phone listening to headphones

In vitro gametogenesis: the science has to be right, and it ...

In vitro gametogenesis (IVG) holds much potential for same-sex couples and women of a more advanced age struggling with infertility, but the question is whether we’re quite there yet.

R&D

Proving ROI for digital endpoints

The costs associated with clinical trials are a major bottleneck to drug development and affordability.

Patients

Clinical trials: Their design, location, and, potentially, t...

Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.